Search

Home > ESC Cardio Talk > ESC Congress 2019 - Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial
Podcast: ESC Cardio Talk
Episode:

ESC Congress 2019 - Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial
Category: Health
Duration: 00:09:47
Publish Date: 2019-09-02 10:44:49
Description:

With Roxana Mehran, The Mount Sinai Hospital - USA, Jan Steffel, University Hospital Zurich - Switzerland & Diana Gorog, University of Hertfordshire - UK

Link to paper:
Total Play: 0